Your new post is loading...
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Genetic Engineering in the Press by GEG
36.1K views |
+0 today
In a potential $1 billion deal, Roche entered a collaboration agreement with Cambridge, MA-based Blueprint Medicines for the development of up to five small molecule cancer immunotherapies, Blueprint said on Tuesday.